Your session is about to expire
← Back to Search
FAPi & PSMA PET/CT Imaging for Cancer Detection
Study Summary
This trial is using a new imaging technique, FAPi PET/CT, to study how well it can detect cancer in patients with non-prostate cancer. The team is also interested in using another new imaging technique, PSMA PET/CT. Patients will have PET/CT scans with either the FAPI or PSMA tracer. This trial is to see if these new techniques are effective in detecting cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for surgery to remove my cancer.I haven't started new cancer treatments between my initial and follow-up PET/CT scans.I can stay still for up to an hour for a scan.I have one of the listed types of cancer.I can follow the study's required procedures.
- Group 1: Basic Science (68Ga-FAPi-46 PET/CT, 68Ga-PSMA-11 PET/CT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots for prospective participants in this medical experiment?
"According to clinicaltrials.gov, this study is actively enrolling participants into its research cohort. The trial was initially posted on November 5th 2019 and underwent its most recent revision on the 29th of November 2022."
How many participants can be included in this research project?
"Indeed, according to clinicaltrials.gov, this medical study is actively enrolling participants at the moment. It was first published on November 5th 2019 and recently updated on November 29th 2022 with a maximum enrolment of 30 patients across 1 site."
Share this study with friends
Copy Link
Messenger